| Health Net Comm & Medi-Cal Plan | Therapeutic Utilization of Inhaled Nitric Oxide | 2025-04-01 |
| Health Net Comm & Medi-Cal Plan | Transcranial Magnetic Stimulation | 2025-04-01 |
| HealthPartners | Advanced drug therapy for pulmonary hypertension | 2025-04-01 |
| HealthPartners | Advanced drug therapy for pulmonary hypertension: | 2025-04-01 |
| HealthPartners | Alemtuzumab (Lemtrada®) | 2025-04-01 |
| HealthPartners | Alemtuzumab (Lemtrada™) – Minnesota Health Care | 2025-04-01 |
| HealthPartners | Allogeneic processed thymus tissue–agdc (Rethymic | 2025-04-01 |
| HealthPartners | Asparaginase erwinia chrysanthemi (recombinant)- | 2025-04-01 |
| HealthPartners | Atypical antipsychotic injections (Aristada™, and | 2025-04-01 |
| HealthPartners | Belatacept (Nulojix®) – Minnesota Health Care | 2025-04-01 |